Physician profile
Bruce E Fischer
NPI 1598766552
$598.14
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $339 · 2020: $129 · 2021: $115 · 2022: $15.34.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $87.29 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $82.96 | 2019-2020 | |
| Pfizer INC. | $62.95 | 2019-2021 | |
| Glaxosmithkline, LLC. | $62.20 | 2020-2021 | |
| Novo Nordisk INC | $60.85 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $51.91 | 2019 | |
| Sanofi-Aventis U.S. LLC | $51.62 | 2021 | |
| Merck Sharp & Dohme LLC | $37.69 | 2019-2021 | |
| Amarin Pharma, INC. | $23.51 | 2019 | |
| Vanda Pharmaceuticals INC. | $18.17 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.97 | 2021 | |
| Lilly USA, LLC | $15.34 | 2022 | |
| Ironshore Pharmaceuticals INC. | $13.80 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.88 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Fischer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.